전이성 흑색종에서 종양 침윤 림프구 치료제 Lifileucel

Sarnaik 등(Wed,)이 이 문제를 연구했습니다.

www.synapsesocial.com/papers/69ed7fd37beaa90d72fab8f5 — DOI: https://doi.org/10.1200/jco.21.00612

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. P865 Safety & efficacy of lifileucel (LN-144) tumor infiltrating lymphocyte therapy in metastatic melanoma patients after progression on multiple therapies – independent review committee data update· 2020 · 3 citations
2. 1053P Iovance generation-2 tumour-infiltrating lymphocyte (TIL) product is reinvigorated during the manufacturing process· 2020 · 8 citations
3. Signatures of mutational processes in human cancer· 2013 · 10,087 citations
4. A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade· 2018 · 1,173 citations
5. What to Do When Anti-PD-1 Therapy Fails in Patients With Melanoma.· 2019 · 20 citations